Interacting Drugs |
Daunorubicin citrate (liposomal) vs Taxane Derivatives |
Security Level |
|
Mechanism |
Taxane Derivatives: May enhance the adverse/toxic effect of Antineoplastic Agents (Anthracycline). Taxane Derivatives may increase the serum concentration of Antineoplastic Agents (Anthracycline). Taxane Derivatives may also increase the formation of toxic anthracycline metabolites in heart tissue. |
Management |
Consider therapy modification |
Daunorubicin citrate (liposomal) vs Taxane Derivatives
Post Review about Daunorubicin citrate (liposomal) vs Taxane Derivatives Click here to cancel reply.
Other Interactions of Daunorubicin citrate (liposomal)
Other Interactions of Taxane Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.